CD61 - Overview: CD61 Immunostain, Technical Component Only
Identification of micromegakaryocytes, cytologically abnormal megkaryocytes, and megakaryoblasts
CTSK - Overview: Cathepsin K Immunostain, Technical Component Only
Evaluation for perivascular epithelioid cell neoplasms (PEComas), alveolar soft part sarcoma, and translocation-associated renal cell carcinomas
SEAS - Overview: Seasonal Inhalants Allergen Profile, Serum
Establishing a diagnosis of an allergy to seasonal inhalants Defining the allergen responsible for eliciting signs and symptoms Identifying allergens: -Responsible for allergic response and/or anaphylactic episode -To confirm...
ASYN - Overview: Alpha-Synuclein Immunostain, Technical Component Only
Identification of alpha-synuclein in neurogenerative disorders
SES - Overview: Selenium, Serum
Monitoring selenium replacement therapy
FCDUB - Overview: Barbiturates, Umbilical Cord Tissue
Barbiturates, Umbilical Cord Tissue
CFNPC - Overview: Cytology FNA (Bill Only)
Cytology FNA (Bill Only)
FCDUE - Overview: Gabapentin, Umbilical Cord Tissue
Gabapentin, Umbilical Cord Tissue
KAIPC - Overview: KappaLambda IHC (Bill Only)
KappaLambda IHC (Bill Only)
FCDX2 - Overview: Mitragynine Confirmation (Qualitative), Umbilical Cord Tissue
Mitragynine Confirmation (Qualitative), Umbilical Cord Tissue
Category A - Mayo Clinic Laboratories
How do I determine if my specimen is a Category A infectious substance affecting humans? See Category A Infectious Substances. By law, an......
Guidance on subtyping of influenza A test results - Insights
Mayo Clinic Laboratories’ guidance for subtyping influenza A in response to a CDC advisory for hospitalized patients...
Category A Infectious Substances - Mayo Clinic Laboratories
Category A Infectious Substances The Dangerous Goods section of the International Air Transport Association (IATA) website provides a "Classification of Infectious Substances" document (pdf)...
Testing for Antibodies to SS-A/Ro in Autoimmune Diseases - Insights
In this month’s “Hot Topic,” Anne Tebo, Ph.D., discusses recent updates in the testing for anti-SS-A/Ro antibodies in systemic autoimmune rheumatic diseases....
A recent Mayo Clinic study has found that many U.S. health care providers are habitually ordering a mostly unnecessary, and quite expensive, genetic test to identify a patient’s hereditary risk of venous...